Atlantic Private Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.3K Hold
1,043
0.02% 157
2025
Q4
$26K Buy
1,043
+41
+4% +$1.03K 0.02% 156
2025
Q3
$25.5K Buy
1,002
+2
+0.2% +$49 0.02% 141
2025
Q2
$24.2K Hold
1,000
0.02% 145
2025
Q1
$25.3K Hold
1,000
0.02% 147
2024
Q4
$26.5K Hold
1,000
0.02% 126
2024
Q3
$28.9K Buy
+1,000
New +$29.2K 0.02% 111

Other funds holding PFE

Atlantic Private Wealth's PFE Position: Q1 2026 in Review

Atlantic Private Wealth held its Pfizer (PFE) position steady in Q1 2026 at 1,043 shares worth $29.3K. The position accounts for 0.02% of the portfolio, ranked #157.

Atlantic Private Wealth first reported a position in PFE in Q3 2024 and has held it in 7 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Atlantic Private Wealth held 1,043 shares of Pfizer worth $29.3K as of Q1 2026.
  • Atlantic Private Wealth left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.02% of Atlantic Private Wealth's portfolio in Q1 2026, its #157 holding.
  • Atlantic Private Wealth first reported a position in Pfizer in Q3 2024 and has held it in 7 quarters since.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Atlantic Private Wealth's 13F filing for Q1 2026, filed 8 May 2026.